Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 27Genitourinary 16Thoracic 14Gynecologic 14Other hematologic neoplasm 13Lymphoid 11Head & Neck 10Breast 10CNS 9Dermatologic 7Plasma cell 5Tumor-Agnostic 3Myeloid 3Sarcoma 2Other solid neoplasm 2Endocrine 2Classical hematology 2Other neoplasm 1Other 1

Conditions

Retinoblastoma 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 124Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 25Filgrastim 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Observation × Other solid neoplasm × Clear all
NCT05873608 2026-04-06

Communication Issues in Patient and Provider Discussions of Immunotherapy

Emory University

Phase NA Recruiting
125 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting
195 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡